The Bottom Line Retatrutide is a powerful new triple-agonist medication, and the specific research on it and alcohol is still early
Summary: Results from retatrutide typically become meaningful from months 36, with Phase 2 trial data showing continued weight loss through 48 weeks at higher doses
Additionally, their overall health might decrease unless they incorporate nutrient-dense whole foods that provide other vitamins, minerals, and essential fatty acids, all of which increase GLP-1 naturally
Pouran Faghri Dr
GLP-1 medications offer many potential benefits, such as weight loss, type 2 diabetes management, and lower blood pressure
Day JW, Ottaway N, Patterson JT, Gelfanov V, Smiley D, Gidda J, et al